Brachytherapy
Volume 7, Issue 3 , Pages 260-266 , July 2008

Radiotherapy doses at special reference points correlate with the outcome of cervical cancer therapy

  • Ryo-ichi Yoshimura

      Affiliations

    • Department of Radiology, Tokyo Medical and Dental University, Tokyo, Japan
    • Corresponding Author InformationCorresponding author. Department of Radiology, Tokyo Medical and Dental University, 5-45, Yushima 1-chome, Bunkyo-ku, Tokyo, Japan 113-8519. Tel.: +81-3-58035311; fax: +81-3-58030147.
    • ,
  • Keiji Hayashi

      Affiliations

    • Department of Radiology, Tokyo Medical and Dental University, Tokyo, Japan
    • ,
  • Fumio Ayukawa

      Affiliations

    • Department of Radiology, Tokyo Medical and Dental University, Tokyo, Japan
    • ,
  • Kazuma Toda

      Affiliations

    • Department of Radiology, Tokyo Medical and Dental University, Tokyo, Japan
    • ,
  • Masaru Iwata

      Affiliations

    • Department of Radiology, Toride Kyodo General Hospital, Ibaraki, Japan
    • ,
  • Sayako Oota

      Affiliations

    • Department of Radiology, Tokyo Medical and Dental University, Tokyo, Japan
    • ,
  • Akihiko Hoshi

      Affiliations

    • Department of Radiology, Musashino Red Cross Hospital, Tokyo, Japan
    • ,
  • Masaru Wakatsuki

      Affiliations

    • Department of Radiology, Toranomon Hospital, Tokyo, Japan
    • ,
  • Hiromasa Kurosaki

      Affiliations

    • Department of Radiology, Funabashi Medical Center Hospital, Chiba, Japan
    • ,
  • Atsushi Okazaki

      Affiliations

    • Department of Radiology, Toranomon Hospital, Tokyo, Japan
    • ,
  • Hitoshi Shibuya

      Affiliations

    • Department of Radiology, Tokyo Medical and Dental University, Tokyo, Japan

Received 25 August 2007 ,Revised 24 March 2008 ,Accepted 25 March 2008.

References 

  1. Nag S, Erickson B, Thomadsen B, et al. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 2000;48:201–211
  2. Cetingoz R, Ataman OU, Tuncel N, et al. Optimization in high dose rate brachytherapy for utero-vaginal applications. Radiother Oncol. 2001;58:31–36
  3. Nag S, Cardenes H, Chang S, et al. Proposed guidelines for image-based intracavitary brachytherapy for cervical carcinoma: Report from Image-Guided Brachytherapy Working Group. Int J Radiat Oncol Biol Phys. 2004;60:1160–1172
  4. Nakano T, Kato S, Ohno T, et al. Long-term results of high-dose rate intracavitary brachytherapy for squamous cell carcinoma of the uterine cervix. Cancer. 2005;103:92–101
  5. Tanaka E, Suzuki O, Oh RJ, et al. Intracavitary brachytherapy for carcinoma of the uterine cervix—Comparison of HDR (Ir-192) and MDR (CS-137). Radiat Med. 2006;24:50–57
  6. Hareyama M, Sakata K, Oouchi A, et al. High-dose-rate versus low-dose-rate intracavitary therapy for carcinoma of the uterine cervix: A randomized trial. Cancer. 2002;94:117–124
  7. Okkan S, Atkovar G, Sahinler I, et al. Results and complications of high dose rate and low dose rate brachytherapy in carcinoma of the cervix: Cerrahpasa experience. Radiother Oncol. 2003;67:97–105
  8. Petereit DG, Pearcey R. Literature analysis of high dose rate brachytherapy fraction schedules in the treatment of cervical cancer: Is there an optimal fractionation schedule?. Int J Radiat Oncol Biol Phys. 1999;43:359–366
  9. Wachter-Gerstner N, Wachter S, Reinstadler E, et al. The impact of sectional imaging on dose escalation in endocavitary HDR-brachytherapy of cervical cancer: Results of a prospective comparative trial. Radiother Oncol. 2003;68:51–59
  10. DeWitt KD, Hsu CJ, Speight J, et al. 3D inverse treatment planning for the tandem and ovoid applicator in cervical cancer. Int J Radiat Oncol Biol Phys. 2005;63:1270–1274
  11. Fellner C, Potter R, Knocke TH, et al. Comparison of radiography- and computed tomography-based treatment planning in cervix cancer in brachytherapy with specific attention to some quality assurance aspects. Radiother Oncol. 2001;58:53–62
  12. Nag S, Gupta N. A simple method of obtaining equivalent dose for use in HDR brachytherapy. Int J Radiat Oncol Biol Phys. 2000;46:507–513
  13. Kim TH, Choi J, Park SY, et al. Dosimetric parameters that predict late rectal complications after curative radiotherapy in patients with uterine cervical carcinoma. Cancer. 2005;104:1304–1311
  14. Lee SW, Suh CO, Chung EJ, et al. Dose optimization of fractionated external radiation and high-dose-rate intracavitary brachytherapy for FIGO stage 1B uterine cervical carcinoma. Int J Radiat Oncol Biol Phys. 2002;52:1338–1344
  15. Beck-Bornholdt HP, Dubben HH. Potential pitfalls in the use of p-values and in interpretation of significance levels. Radiother Oncol. 1994;33:171–176
  16. Toita T, Kakinohana Y, Ogawa K, et al. Combination external beam radiotherapy and high-dose-rate intracavitary brachytherapy for uterine cervical cancer analysis of dose and fractionation schedule. Int J Radiat Oncol Biol Phys. 2003;56:1344–1353
  17. Malyapa RS, Mutic S, Low DA, et al. Physiologic FDG-PET three-dimensional brachytherapy treatment planning for cervical cancer. Int J Radiat Oncol Biol Phys. 2002;54:1140–1146
  18. Eifel PJ, Thomas WW, Smith TL, et al. The relationship between brachytherapy dose and outcome in patients with bulky endocervical tumors treated with radiation alone. Int J Radiat Oncol Biol Phys. 1993;28:113–118
  19. Potter R, Dimopoulos J, Bachtiary B, et al. 3D conformal HDR-brachy- and external beam therapy plus simultaneous cisplatin for high-risk cervical cancer: Clinical experience with 3 year follow-up. Radiother Oncol. 2006;79:80–86
  20. Kirisits C, Potter R, Lang S, et al. Dose and volume parameters for MRI-based treatment planning in intracavitary brachytherapy for cervical cancer. Int J Radiat Oncol Biol Phys. 2005;62:901–911
  21. Potter R, Limbergen EV, Gerstner N, et al. Survey of the use of the ICRU 38 in recording and reporting cervical cancer brachytherapy. Radiother Oncol. 2001;58:11–18
  22. Clark BG, Souhami L, Roman TN, et al. The prediction of late rectal complications in patients treated with high dose-rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 1997;38:989–993
  23. Ogino I, Kitamura T, Okamoto N, et al. Late rectal complication following high dose rate intracavitary brachytherapy in cancer of the cervix. Int J Radiat Oncol Biol Phys. 1995;31:725–734
  24. Sueyama H, Nakano M, Sakumoto K, et al. Intra-arterial chemotherapy with cisplatin followed by radical radiotherapy for locally advanced cervical cancer. Gynecol Oncol. 1995;59:327–332
  25. Haie-Meder C, Potter R, Van Limbergen E, et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (1): Concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol. 2005;74:235–245
  26. Brooks S, Bownes P, Lowe G, et al. Cervical brachytherapy utilizing ring applicator: comparison of standard and conformal loading. Int J Radiat Oncol Biol Phys. 2005;63:934–939

PII: S1538-4721(08)00555-2

doi: 10.1016/j.brachy.2008.03.002

Brachytherapy
Volume 7, Issue 3 , Pages 260-266 , July 2008

Article Tools

* Image Usage & Resolution